NCT05181800View on ClinicalTrials.gov

FIRMAGON® Intensive Drug Monitoring

CompletedOBSERVATIONAL
Enrollment

1,454

Participants

Timeline

Start Date

August 20, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Prostate Cancer
Interventions
OTHER

Degarelix Cohort

Non-interventional

Trial Locations (1)

Unknown

China Primary Healthcare Foundation, Beijing

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY